Nuveen’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-409,004
Closed -$62.7M 3631
2021
Q1
$62.7M Buy
409,004
+56,312
+16% +$7.65M 0.02% 621
2020
Q4
$44.2M Buy
352,692
+80,678
+30% +$9.02M 0.02% 755
2020
Q3
$27.6M Sell
272,014
-116,797
-30% -$11.9M 0.01% 875
2020
Q2
$37.8M Sell
388,811
-96,068
-20% -$8.94M 0.02% 661
2020
Q1
$40.3M Sell
484,879
-109,101
-18% -$10.6M 0.02% 570
2019
Q4
$66M Sell
593,980
-44,639
-7% -$4.59M 0.03% 558
2019
Q3
$63.4M Sell
638,619
-11,671
-2% -$1.16M 0.03% 558
2019
Q2
$64.5M Buy
650,290
+647,039
+19,903% +$61.8M 0.03% 566
2019
Q1
$359K Sell
3,251
-8,972
-73% -$938K ﹤0.01% 896
2018
Q4
$1.12M Sell
12,223
-1,660
-12% -$168K 0.01% 700
2018
Q3
$1.53M Sell
13,883
-21,963
-61% -$2.29M 0.01% 688
2018
Q2
$3.35M Buy
35,846
+13,999
+64% +$1.21M 0.02% 524
2018
Q1
$1.81M Buy
21,847
+6,976
+47% +$620K 0.01% 629
2017
Q4
$1.35M Buy
14,871
+29
+0.2% +$2.41K 0.01% 673
2017
Q3
$1.13M Buy
14,842
+4,927
+50% +$372K 0.01% 731
2017
Q2
$744K Buy
9,915
+4,396
+80% +$305K ﹤0.01% 824
2017
Q1
$360K Buy
+5,519
New +$325K ﹤0.01% 1240

Other funds holding PRAH

Nuveen's PRAH Position: Q2 2021 in Review

Nuveen sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 409,004 shares — an estimated $62.7M sold.

Nuveen first reported a position in PRAH in Q1 2017 and held it in 17 quarters. The position peaked at $66M in Q4 2019. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Nuveen reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 409,004 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $62.7M.
  • Nuveen first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 17 quarters.
  • Nuveen's PRA Health Sciences, Inc. position peaked at $66M in Q4 2019.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.